title: Evolution from fibrinolytic therapy to a fibrinolytic strategy for patients with ST-segment-elevation myocardial infarction.
authors.affiliation: From the Division of Cardiovascular Diseases, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI. ebates@umich.edu.
authors.forename: Eric R
authors.initials: ER
authors.lastname: Bates
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality*; D062645:Percutaneous Coronary Intervention / Q000401:mortality*; D000077785:Tenecteplase; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase
keywords: Editorials; fibrinolysis; myocardial infarction; percutaneous coronary intervention; reperfusion therapy